Argentine study finds pseudoexfoliation in 2.88% of eye clinic patients
The yearlong study covered patients aged 40 or older at 199 centers, offering a clinical benchmark rather than a population-wide estimate.

A nationwide study at 199 ophthalmology centers in Argentina identified pseudoexfoliation syndrome in 2.88% of patients aged 40 or older who attended routine eye appointments. The findings provide a clinical benchmark for an eye condition recognized as a leading identifiable cause of secondary glaucoma, but they do not estimate how common it is across Argentina’s entire population.
The PEXAR Study counted 2,848 cases among 98,933 patients examined from July 1, 2024, through June 30, 2025. A follow-up analysis using a stricter diagnostic definition found 2,844 cases, or 2.87%, leaving the overall result nearly unchanged.
Pseudoexfoliation syndrome involves visible deposits in the eye. It can affect one or both eyes and is clinically relevant because of its association with glaucoma. In the Argentine study, more than half of the patients identified with the syndrome also had clinician-diagnosed glaucoma.
Who was included and what did clinicians find?
Participating ophthalmologists assessed patients during routine care, recording cases when they saw at least one specified sign during a slit-lamp or gonioscopic examination. The study included people aged 40 and older; it was not a community survey of people who had not sought eye care.
Patients with the syndrome had a mean age of 75. Women made up 59% of the identified group. The condition affected both eyes in 54.2% of cases and one eye in 45.8%. Clinicians most often observed exfoliative material at the pupillary margin.
Clinician-diagnosed glaucoma was recorded in 58.4% of affected patients, but the examination protocol did not systematically classify glaucoma subtypes. High blood pressure was documented in 52.1%, hearing loss in 22.3% and diabetes in 17.2%.
What the findings can—and cannot—show
The study describes patients seen in routine clinical settings over one year. Because it did not sample the general population, its 2.88% figure should be understood as the observed prevalence among those examined, not a national population estimate.
The authors also caution that the recorded frequencies of high blood pressure, hearing loss and diabetes describe the affected patients; they do not establish that these conditions are more common than in other people or that they cause pseudoexfoliation syndrome. The study’s cross-sectional design provides a snapshot, while the authors say it can inform future population-based and long-term research.
This report draws on information from BIOENGINEER.ORG.
Editorial checks passed Facts, figures and quotes checked against 1 source, 1 official or primary
Add Clinic Near Me as a preferred source on Google



